Search alternatives:
treatment decreased » treatment increases (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
treatment decreased » treatment increases (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
41
-
42
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
43
-
44
Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice.
Published 2023Subjects: -
45
-
46
-
47
-
48
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
49
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
50
-
51
A375 melanoma cells show a higher sensitivity to GAPDH inhibition than normal melanocytes.
Published 2024Subjects: -
52
-
53
-
54
Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus.
Published 2023Subjects: -
55
-
56
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
57
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
58
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
59
-
60